√现场参观 □新闻发布会 证券代码：920275 证券简称：驱动力 公告编号：2025-100 广东驱动力生物科技集团股份有限公司 投资者关系活动记录表 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、 投资者关系活动类别 √特定对象调研 □业绩说明会 □媒体采访 □分析师会议 □路演活动 □其他 二、 投资者关系活动情况 活动时间：2025 年 11 月 15 日 活动地点：公司会议室 参会单位及人员：国泰海通、开源证券、睿和投资、高品投资、量量资产、 个人投资者（排名不分先后）。 上市公司接待人员：公司董事长、总经理刘平祥先生；公司控股股东刘金萍 女士；董事会秘书杨娜女士；财务总监沈佳女士。 三、 投资者关系活动主要内容 在本次投资者关系活动中公司向各位投资者对公司的基本情况、主营业务、 核心技术以及未来发展规划做了简要介绍。本次投资者关系活动的主要问题及公 司对问题的回复概要如下： 回答：谷饲牛料是公司研发团队在反刍领域的一大突破，具有安全、优质、 高效、环保、低成本的优势。采用造血技术、无抗 ...

Core Points - The Shanghai Composite Index closed at 3993.35 points, remaining above the six-month moving average, with a slight decline of 0.24% [1] - The total trading volume of A-shares reached 1,270.245 billion yuan [1] - A total of 49 A-shares have surpassed the six-month moving average today, with notable stocks showing significant deviation rates [1] Summary by Category Stock Performance - Notable stocks with high deviation rates include: - Qudongli (驱动力) with a deviation rate of 5.91% and a daily increase of 7.05% [1] - Lubridge Information (路桥信息) with a deviation rate of 5.60% and a daily increase of 13.08% [1] - Beiyikang (倍益康) with a deviation rate of 4.75% and a daily increase of 7.60% [1] - Other stocks that just crossed the six-month moving average include: - Qianyuan Pharmaceutical (仟源医药) and *ST Jinke (*ST金科) with smaller deviation rates [1] Trading Activity - The trading turnover rate for Qudongli was 3.59%, while Lubridge Information had a turnover rate of 6.91% [1] - The stock with the highest turnover rate was Aipeng Medical (爱朋医疗) at 19.33% with a daily increase of 10.57% [1] Market Trends - The overall market shows a mix of stocks performing well above the six-month moving average, indicating potential bullish sentiment in certain sectors [1]

Core Insights - The animal health sector experienced a 1.04% increase on November 11, with *ST Lvkang leading the gains [1] - The Shanghai Composite Index closed at 4002.76, down 0.39%, while the Shenzhen Component Index closed at 13289.0, down 1.03% [1] Stock Performance - *ST Lvkang (002868) closed at 35.02, up 5.01% with a trading volume of 1196 lots and a transaction value of 4.1884 million yuan [1] - Other notable performers included: - Qudongli (920275) at 10.36, up 4.65% [1] - Yongshun Biological (920729) at 9.97, up 2.15% [1] - Biological Shares (600201) at 10.63, up 1.24% [1] - Plai Ke (603566) at 14.42, up 1.19% [1] Capital Flow - The animal health sector saw a net outflow of 2.5437 million yuan from institutional investors and 7.7575 million yuan from speculative funds, while retail investors had a net inflow of 10.3012 million yuan [1] - Specific stock capital flows included: - Biological Shares (600201) with a net inflow of over 9.2092 million yuan from institutional investors [2] - *ST Lvkang (002868) had a net inflow of 1.1031 million yuan from retail investors [2] - Huayi Biological (603718) experienced a net outflow of 4.1338 million yuan from institutional investors [2]

Market Overview - The animal health sector experienced a decline of 2.79% on October 30, with Jinhe Biology leading the drop [1] - The Shanghai Composite Index closed at 3986.9, down 0.73%, while the Shenzhen Component Index closed at 13532.13, down 1.16% [1] Individual Stock Performance - Jinhe Biology (002688) closed at 6.25, down 7.13% with a trading volume of 578,000 shares and a transaction value of 367 million yuan [1] - Keqian Biology (688526) closed at 16.15, down 6.76% with a trading volume of 139,800 shares and a transaction value of 228 million yuan [1] - Maofeng Holdings (002141) closed at 3.92, down 5.08% with a trading volume of 461,300 shares and a transaction value of 18.3 million yuan [1] - Other notable declines include Dayu Biology (920970) down 2.69%, and Pulaike (603566) down 2.68% [1] Capital Flow Analysis - The animal health sector saw a net outflow of 84.7 million yuan from institutional investors, while retail investors experienced a net outflow of 16.5 million yuan [1] - Speculative funds recorded a net inflow of 101 million yuan [1] Detailed Capital Flow for Selected Stocks - Keqian Biology (688526) had a net inflow of 39.6 million yuan from institutional investors, while retail investors saw a net outflow of 60.9 million yuan [2] - Huisheng Biology (300871) experienced a net inflow of 18.3 million yuan from institutional investors, with a net outflow of 21.2 million yuan from retail investors [2] - Other stocks like Pulaike (603566) and Maofeng Holdings (002141) also reported significant net outflows from institutional investors [2]

证券代码：920275 证券简称：驱动力 公告编号：2025-099 广东驱动力生物科技集团股份有限公司投资者关系管理档 案制度 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、 审议及表决情况 本制度经广东驱动力生物科技集团股份有限公司 2025 年 10 月 27 日第四届 董事会第十次会议审议通过，本议案无需提交股东会审议。 二、 分章节列示制度主要内容： 第三条 公司董事会办公室负责制定并留存投资者关系管理的档案，并由专 人进行收集、整理、归档、保管。在不影响公司正常经营和泄露商业秘密的前提 下，公司其它部门有义务配合董事会办公室进行相关工作。 第一章 总则 第一条 为加强广东驱动力生物科技集团股份有限公司（以下简称"公司"） 投资者关系管理的档案归档、管理工作，有效地保护和利用档案，维护公司合法 权益，根据《中华人民共和国公司法》《中华人民共和国证券法》《北京证券交易 所股票上市规则》等有关法律、法规、规范性文件及《广东驱动力生物科技集团 股份有限公司章程》（以下简称"《公司章程》"）的规 ...

证券代码：920275 证券简称：驱动力 公告编号：2025-097 广东驱动力生物科技集团股份有限公司高级管理人员变动公 告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、误导 性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带法律责任。 一、高级管理人员任命的基本情况 公司于 2025 年 10 月 27 日召开第四届董事会第十次会议，审议并通过了《关于聘 任公司董事会秘书的议案》，上述议案表决结果：同意 5 票，反对 0 票，弃权 0 票。 聘任杨娜女士为公司董事会秘书，任职期限自第四届董事会第十次会议审议通过之 日起至第四届董事会任期届满之日止，自 2025 年 10 月 27 日起生效。该人员持有公司 股份 0 股，占公司股本的 0%，不是失信联合惩戒对象。 （上述人员简历详见附件） 二、高级管理人员离任的基本情况 本公司叶军强先生，因个人原因辞任，自 2025 年 10 月 24 日起不再担任董事会秘 书。该人员持有公司股份 0 股，占公司股本的 0%，不是失信联合惩戒对象，离任后不 再担任公司及其控股子公司其它职务，不存在未履行完毕的公开承诺。 公司本次提 ...

证券代码：920275 证券简称：驱动力 公告编号：2025-096 广东驱动力生物科技集团股份有限公司 第四届董事会第十次会议决议公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、会议召开和出席情况 （一）会议召开情况 1.会议召开时间：2025 年 10 月 27 日 2.会议召开地点：公司会议室 3.会议召开方式：现场 4.发出董事会会议通知的时间和方式：2025 年 10 月 24 日以书面方式发出 5.会议主持人：董事长刘平祥先生 6.会议列席人员：公司高级管理人员 7.召开情况合法合规的说明： 本次会议的召集、召开符合《公司法》和《公司章程》的规定，决议合法有 效。 （一）审议通过《关于聘任公司董事会秘书的议案》 1.议案内容： 叶军强先生因个人原因，申请辞去公司董事会秘书职务，辞任后不在公司担 任任何职务。公司拟聘任杨娜女士担任公司董事会秘书职务，任期自董事会审议 通过之日起至公司第四届董事会期限届满之日止。 2.议案表决结果：同意 5 票；反对 0 票；弃权 0 票。 本议案已经 ...

Core Viewpoint - The animal health sector experienced a slight increase of 0.21% on October 24, with significant contributions from specific stocks, particularly Biological Shares, which led the gains [1] Market Performance - The Shanghai Composite Index closed at 3950.31, up 0.71% - The Shenzhen Component Index closed at 13289.18, up 2.02% [1] Stock Performance in Animal Health Sector - Biological Shares (600201) closed at 10.77, up 2.87% with a trading volume of 311,900 shares and a turnover of 333 million yuan - Other notable stocks include: - *ST Green Health (002868): closed at 29.09, up 0.66% - Shunlian Biological (688098): closed at 10.75, up 0.66% - Huisheng Biological (300871): closed at 20.75, up 0.48% - Yongshun Biological (920729): closed at 9.68, up 0.31% - Jinhe Biological (002688): closed at 6.68, unchanged [1] Capital Flow Analysis - The animal health sector saw a net inflow of 8.6031 million yuan from institutional investors, while retail investors experienced a net outflow of 24.4195 million yuan [2] - The breakdown of capital flow indicates: - Repu Biological (300119) had a net inflow of 9.2707 million yuan from institutional investors - Biological Shares (600201) saw a net inflow of 8.4244 million yuan - Kexin Biological (688526) had a net inflow of 5.4428 million yuan from institutional investors [3]

Core Viewpoint - The animal health sector experienced a decline of 0.36% on October 22, with Dayu Biological leading the drop. The Shanghai Composite Index closed at 3913.76, down 0.07%, while the Shenzhen Component Index closed at 12996.61, down 0.62% [1]. Stock Performance Summary - The following stocks in the animal health sector showed varied performance: - Shengwu Co. (600201) closed at 10.78, up 0.56% with a trading volume of 327,000 shares and a turnover of 351 million yuan - Ruipu Biological (300119) closed at 21.50, up 0.51% with a trading volume of 73,200 shares and a turnover of 158 million yuan - Haili Biological (603718) closed at 7.04, up 0.28% with a trading volume of 44,200 shares and a turnover of 31.17 million yuan - Dayu Biological (920970) closed at 9.46, down 1.25% with a trading volume of 20,800 shares and a turnover of 19.89 million yuan - ST Lvkang (002868) closed at 28.49, down 1.18% with a trading volume of 9,904 shares and a turnover of 28.26 million yuan [1][2]. Capital Flow Analysis - The animal health sector saw a net outflow of 47.45 million yuan from institutional investors, while retail investors contributed a net inflow of 36.66 million yuan. Speculative funds recorded a net inflow of 10.80 million yuan [2][3]. - Specific stock capital flows included: - Shunlian Biological (688098) had a net inflow of 6.94 million yuan from institutional investors but a net outflow of 12.58 million yuan from retail investors - Ruipu Biological (300119) experienced a net outflow of 2.94 million yuan from institutional investors, with a significant net inflow of 13.74 million yuan from speculative funds [3].

证券代码：920275 证券简称：驱动力 公告编号：2025-095 广东驱动力生物科技集团股份有限公司 关于对北京证券交易所半年报问询函回复的公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 北京证券交易所上市公司管理部： 广东驱动力生物科技集团股份有限公司(以下简称"公司")于 2025 年 9 月 26 日收到北京证券交易所上市公司管理部下发的《关于对广东驱动力生物科技 集团股份有限公司的半年报问询函》（半年报问询函【2025】第 002 号，以下简 称"问询函"），公司及公司董事会高度重视，立即组织相关部门、人员就问询 函中相关问题进行了认真核查并落实。现对问询函所列问题回复如下： 问题一：关于经营业绩 你公司 2025 年上半年实现营业收入 3,259.48 万元，同比下降 0.46%；归属 于上市公司股东的净利润 161.30 万元，同比下降 71.24%；综合毛利率 30.77%， 同比下降 8.67 个百分点。 分产品看，造血类产品实现营业收入 3,158.52 万元，同比下降 2. ...